Results 171 to 180 of about 21,819 (222)

Critical role of empiric antitoxin therapy in suspected <i>Clostridium baratii</i> infection: a case report. [PDF]

ASM Case Rep
Polashenski M, Perry MJ, Aggarwal A.
europepmc   +1 more source

Clinical Effectiveness of IncobotulinumtoxinA Using a Standardized Protocol in the Management of Myogenous Temporomandibular Disorders: A 12-Month Retrospective Study. [PDF]

Toxins (Basel)
Ângelo DF, Cardoso HJ, Sarkis M, Santos K, Maffia F, Sanz D, Salvado F.   +6 more
europepmc   +1 more source

Dual-mode Sequential Radiofrequency in Challenging Skin Types: Case Reports in Atopic-prone and Previously Treated Patients. [PDF]

Plast Reconstr Surg Glob Open
Lee J, Kumar N.
europepmc   +1 more source

Enhanced Efficacy of Post-Procedural Skin Care: A Double-Blind, Randomized, Vehicle-Controlled, Split-Face Clinical Study Assessing a Novel Neuropeptide Serum Following Botulinum Toxin Injection. [PDF]

Clin Cosmet Investig Dermatol
Lupin M, Brieva P, Dayeh NR, White S.
europepmc   +1 more source

Botulinum Toxin Treatment of Stiff Person Syndrome-A Critical Review and Update. [PDF]

Toxins (Basel)
Tohidian AG, Comtesse SM, Etemadmoghadam S, Jabbari B.   +3 more
europepmc   +1 more source

Combination Therapy with Oral Doxycycline and Intradermal Botulinum Toxin Type A for Moderate-to-Severe Rosacea: A Randomized Controlled Trial.

Indian J Dermatol
Nguyen TT, Le DH, Vu HT, Vu LH, Vu MN, Pham PTM.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Botulinum toxin type E: A review

Dermatological Reviews, 2022
AbstractBackgroundBotulinum toxin type A (BoNT‐A) and botulinum toxin type B are the only two serotypes of botulinum toxin currently available for therapeutic use. Recently, botulinum toxin type E (BoNT‐E) has been explored for clinical use due to its pharmacological properties.
Emily Lebowitz, Diane Berson
openaire   +1 more source